31.08.2018 • NewsElaine BurridgeMerckProcter & Gamble

EU Clears Merck’s Consumer Health Sale to P&G

EU Clears Merck’s Consumer Health Sale to P&G
EU Clears Merck’s Consumer Health Sale to P&G

The European Commission has approved the sale by Merck KGaA of its global consumer health business to Procter & Gamble (P&G). The regulator said it had no competition concerns, noting that the activities of both companies are generally complementary and give rise to a limited number of horizontal overlaps, with sufficient competition remaining post-merger.

In April of this year, the German company signed an agreement to sell the division to the US consumer products giant for around €3.4 billion in cash. The acquisition adds Merck’s vitamin and food supplements, such as Seven Seas, to P&G’s portfolio that features a range of over-the-counter medicines including Vicks cough and cold products, along with well-known brands such as Pampers diapers and Gillette razors.

The deal, which is said to be one of the biggest that P&G has done in recent years, also boosts the US group’s presence in Latin America and Asia.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.